Monograph
N06BA04 - Methylphenidate |
Propably not porphyrinogenic |
PNP |
Rationale
Not CYP-metabolised. No data pointing to CYP-induction. References consider it safe.
Chemical description
Narcotic psychostimulant used in treatment of attention deficit hyperactivity (ADH). Metabolized by de-esterification to alphaphenylpiperidine acetic acid. No data pointing to CYP-induction. EPI-list: safe. South African list: use. Australian list: safe.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025